Skip to content
Sign in

USNA · NYSE

USANA Health Sciences (USNA) Stock Price & Fundamentals

$849.15−1.12%−$9.66End-of-day price as of Oct 9, 2026

USANA Health Sciences (USNA) closed at $849.15 on Oct 9, 2026, down 1.12% from the previous close of $858.81.

Share price, past year

1Y +18.29%

52-week range $666.75 – $867.44. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$849.15
Sep 30, 2026$858.41
Aug 31, 2026$825.86
Jul 31, 2026$790.66
Jun 30, 2026$814.76
May 29, 2026$806.94
Apr 30, 2026$841.94
Mar 31, 2026$763.52
Feb 27, 2026$730.07
Jan 30, 2026$675.90
Dec 31, 2025$680.95
Nov 28, 2025$703.92
Oct 31, 2025$737.19

Key statistics

Market cap
$15.68B
P/E (TTM)
—
EPS (TTM)
−$1.18
Revenue (TTM)
$913.36M
Net income (TTM)
−$22.16M
Shares outstanding
18.5M
Dividend yield
—
52-week range
$666.75 – $867.44

USANA Health Sciences's market cap is $15.68B, based on a share price of $849.15 and 18.5M shares outstanding as of Jul 4, 2026.

Financials

USANA Health Sciences reported revenue of $925.26M for fiscal 2025.

USANA Health Sciences earned net income of $10.76M in fiscal 2025, a net margin of 1.2%.

Annual revenue

FY14FY15FY16FY17FY18FY20FY21FY22FY23FY25
Annual revenue by fiscal year; the table below lists the values.
USANA Health Sciences annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Jan 3, 2026$925.26M+8.3%$10.76M1.2%$0.58$8.53M
FY2023ended Dec 28, 2024$854.50M−7.2%$42.03M4.9%$2.19$50.92M
FY2022ended Dec 30, 2023$921.01M−7.8%$63.79M6.9%$3.30$56.15M
FY2021ended Dec 31, 2022$998.60M−12.0%$69.35M6.9%$3.59$93.50M
FY2020ended Jan 2, 2021$1.13B+7.0%$124.66M11.0%$5.86$145.31M
FY2018ended Dec 28, 2019$1.06B−10.8%$100.53M9.5%$4.41$110.16M
FY2017ended Dec 29, 2018$1.19B+13.6%$126.22M10.6%$5.12$140.69M
FY2016ended Dec 30, 2017$1.05B+14.0%$62.54M6.0%$2.53$110.55M
FY2015ended Jan 2, 2016$918.50M+16.2%$100.04M10.9%$3.99$104.19M
FY2014ended Jan 3, 2015$790.47M—$76.64M9.7%$2.80$84.76M
USANA Health Sciences quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jul 4, 2026$223.27M−$21.38M−$1.16
Q1 FY2026ended Apr 4, 2026$250.22M$7.52M$0.41
Q4 FY2025ended Jan 3, 2026$226.20M−$1.78M−$0.07
Q3 FY2025ended Sep 27, 2025$213.67M−$6.52M−$0.36
Q2 FY2025ended Jun 28, 2025$235.85M$9.66M$0.52
Q1 FY2025ended Mar 29, 2025$249.54M$9.40M$0.49
Q4 FY2023ended Dec 28, 2024$213.61M$4.45M$0.23
Q3 FY2023ended Sep 28, 2024$200.22M$10.61M$0.56

Company profile

Name
USANA Health Sciences, Inc.
Ticker
USNA
Exchange
NYSE
Industry (SEC SIC)
Medicinal Chemicals & Botanical Products
Headquarters
3838 West Parkway Blvd., Salt Lake City, UT 84120-6336
Incorporated in
UT
Fiscal year ends
January
SEC CIK
0000896264

Recent SEC filings

Frequently asked questions

What is USANA Health Sciences's stock price?

USANA Health Sciences (USNA) closed at $849.15 on Oct 9, 2026, down 1.12% from the previous close of $858.81.

What is USANA Health Sciences's market cap?

USANA Health Sciences's market cap is $15.68B, based on a share price of $849.15 and 18.5M shares outstanding as of Jul 4, 2026.

How much revenue does USANA Health Sciences make?

USANA Health Sciences reported revenue of $925.26M for fiscal 2025.

Does USANA Health Sciences pay a dividend?

USANA Health Sciences's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from USANA Health Sciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures